These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6883378)

  • 1. LTA: a human lung tumor-associated antigen common to primary lung tumors and cultured lung tumor cell lines.
    Braatz JA; Hua DT; Princler GL
    Cancer Detect Prev; 1983; 6(1-2):173-9. PubMed ID: 6883378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on a purified human lung tumor-associated antigen.
    Braatz JA; Scharfe TR; Princler GL; McIntire KR
    Oncodev Biol Med; 1982; 3(2-3):169-77. PubMed ID: 7122254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of a human lung tumor-associated antigen using an improved radioimmunoassay.
    Braatz JA; Hua DT; Princler GL
    Cancer Res; 1983 Jan; 43(1):110-3. PubMed ID: 6847759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a human lung tumor-associated antigen and development of a radioimmunoassay.
    Braatz JA; Scharfe TR; Princler GL; McIntire KR
    Cancer Res; 1982 Mar; 42(3):849-55. PubMed ID: 7059983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lung tumor-associated antigens of 32,000 daltons molecular weight.
    Kempner DH; Jay MR; Stevens RH
    J Natl Cancer Inst; 1979 Nov; 63(5):1121-9. PubMed ID: 91695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of a squamous cell lung carcinoma-associated antigen, KA-32, in human tissues and sera defined by monoclonal antibody KM-32.
    Hanai N; Shitara K; Yoshida H
    Cancer Res; 1986 Oct; 46(10):5206-10. PubMed ID: 3530436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, stage, and prognosis of lung carcinoma by preoperative assay of lung tumor antigen-sensitive T lymphocytes.
    Ramey WG; Fitzpatrick HF; Hashim GA; Munther AS; Swistel AJ; Burrows WB
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):656-60. PubMed ID: 6968856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and purification of a human lung tumor-associated antigen from a primary lung tumor.
    Princler GL; McIntire KR; Braatz JA
    Cancer Res; 1982 Mar; 42(3):843-8. PubMed ID: 6174216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
    Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
    Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
    Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
    Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T; Takenoyama M; Ichiki Y; Mizukami M; So T; Hanagiri T; Sugio K; Yasumoto K
    Cancer; 2005 Jan; 103(1):200-8. PubMed ID: 15573370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y; Hanagiri T; Takenoyama M; Fukuyama T; Mizukami M; So T; Ichiki Y; Sugaya M; Sugio K; Yasumoto K
    Clin Cancer Res; 2005 Jul; 11(14):5265-72. PubMed ID: 16033845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic heterogeneity of human lung cancers.
    Harłozińska A; Richter R; Albert Z; Zawadzka H
    J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte responses of lung cancer patients to tumor-associated antigen measured by leucine incorporation.
    Roth JA; Holmes EC; Boddie AW; Morton DL
    J Thorac Cardiovasc Surg; 1975 Oct; 70(4):613-8. PubMed ID: 1177475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a new cancer/germline gene, KK-LC-1, encoding an antigen recognized by autologous CTL induced on human lung adenocarcinoma.
    Fukuyama T; Hanagiri T; Takenoyama M; Ichiki Y; Mizukami M; So T; Sugaya M; So T; Sugio K; Yasumoto K
    Cancer Res; 2006 May; 66(9):4922-8. PubMed ID: 16651449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes.
    Chang GC; Liu KJ; Hsieh CL; Hu TS; Charoenfuprasert S; Liu HK; Luh KT; Hsu LH; Wu CW; Ting CC; Chen CY; Chen KC; Yang TY; Chou TY; Wang WH; Whang-Peng J; Shih NY
    Clin Cancer Res; 2006 Oct; 12(19):5746-54. PubMed ID: 17020980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.